偉易達(00303.HK):航運受阻致原材料短缺 料情況持續至年底
偉易達(00303.HK)主席黃子欣表示,雖然新型肺炎疫情於部份市場減退,在家工作情況減少,不過相關設備銷售仍然良好。最大問題是由於疫情下貨櫃提供趕不上需求,造成原材料供應短缺,價格上升,因此雖然銷售仍然錄得增長,毛利率卻受壓,他預計有關情況將維持至今年年底,惟未有披露毛利率受壓或成本上升的幅度。
另外,去年受到疫情影響,演唱會等活動未有舉行,集團的大型音響銷售亦受到影響。惟隨著疫情緩和,相關銷售亦提升。不過集團有見美國市場在最新一輪消費補貼結束後,銷售增長放緩,集團將陸續推出電子教育產品,預計至聖誕節止亦有新產品陸續推出,至公布中期業績時可分享最新銷售情況。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.